Does Trevi Therapeutics Inc (NASDAQ:TRVI) Look Expensive At $2.93? Here’s How To Know.
In last trading session, Trevi Therapeutics Inc (NASDAQ:TRVI) saw 0.45 million shares changing hands with its beta currently measuring 0.85. Company’s recent per share price